August 14 - 16, 2026
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
Photo credit: Destination BC/Alex Strohl
Program Highlights
- Lectures and Scientific Abstracts
- Workshops
- Debates and discussions on key controversies
- Interactive question and answer sessions
- Poster sessions
Key topics will include:
- Basic Science
- Translational Research
- Medical Treatment
- Surgical Treatment
- Phototherapy
- Epidemiology
- Case Reports
- Assessment of vitiligo severity, impact & therapeutic response
- Artificial Intelligence in Vitiligo
7th Vitiligo Congress
Call for Abstracts
The 7th Vitiligo International Congress (VIC7) will be held August 14-16, 2026, at the Hyatt Regency in Vancouver, Canada. Formerly known as the Vitiligo International Symposium and recently held in Egypt in 2024, this meeting will bring together 500–600 leading dermatologists, researchers, healthcare professionals, and patient advocates from around the globe.
Together, we will share the latest advancements in vitiligo diagnosis, management, and care — united under our inspiring 2026 theme: Victory Over Vitiligo in Vancouver. The Scientific Committee invites you to submit abstracts for consideration as oral or poster presentations.
Key Dates
VIC7 Online Abstract Portal open for submissions
Monday, December 15, 2025
Abstract Submission Deadline – extended
Friday, April 10, 2026
Abstract Notification – updated
Friday, May 1, 2026
Presenting Author Registration Deadline
Wednesday, May 27, 2026
Presentation at 7th Vitiligo International Congress
August 14-16, 2026
Key Dates
VIC7 Online Abstract Portal open for submissions
Monday, December 15, 2025
Abstract Submission Deadline
Monday, April 6, 2026
Abstract Notification
Tuesday, April 28, 2026
Presenting Author Registration Deadline
Wednesday, May 27, 2026
Presentation at 7th Vitiligo International Congress (VIC7)
August 14-16, 2026
7th Vitiligo Congress
Program at a Glance
as of March 23, 2026
Invited Speakers
Megan K. Levings, PhD
Professor, Department of Surgery and School of Biomedical Engineering, University of British Columbia
Canada Research Chair in Engineered Immune Tolerance
Director, Advanced Therapeutics Manufacturing Facility
Megan K. Levings, PhD
Session 2: Keynote Presentation
Regulatory T cells to induce immune tolerance
Professor, Department of Surgery and School of Biomedical Engineering, University of British Columbia
Canada Research Chair in Engineered Immune Tolerance
Director, Advanced Therapeutics Manufacturing Facility
Dr. Megan Levings is a Professor in the Department of Surgery and School of Biomedical Engineering at the University of British Columbia and BC Children’s Hospital Research Institute.
Dr. Levings started her career through summer research projects with Dr. James Price, who was studying signalling pathways in drosophila. This experience sparked her interest in genetics and she subsequently pursued graduate training with Dr. John Schrader, in the genetics program at the University of British Columbia. Here she studied cytokine receptors and signalling pathways. After obtaining her PhD in 1998, she joined Dr. Maria Grazia Roncarolo’s lab in Milan, undertaking postdoctoral training in the area of immune regulation. During this time, she conducted pioneering work to define what we now know as regulatory T cells (Tregs), and showed their potential to be isolated and expanded for use as cellular therapy to stop harmful immune responses. Dr. Levings was recruited back to UBC in 2003, joining the Department of Surgery as a Tier II Canada Research Chair in Transplantation. Her lab has continued to advance research into Tregs, most recently using gene editing to re-direct cell specificity and enhance their function. Dr. Levings is also a leader in human immunology more generally, with work to define and optimize biomarkers in autoimmunity leading to mechanistic insight into disease pathogenesis and response to therapy. Dr. Levings is currently President Elect of the Federation of Clinical Immunology Societies and has won numerous awards, including the 2020 YWCA Woman of Distinction, Science, Research & Technology, 2022 Simon Fraser University Outstanding Alumni award, 2022 UBC Faculty of Medicine Distinguished Researcher in the Basic/Foundational Science Category, and the 2025 Canadian Society for Immunology Cinader Award.
Dr. Joe Speaker #2, MD, FRCPC
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
Dr. Joe Speaker #3, MD, FRCPC
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
Dr. Joe Speaker #4, MD, FRCPC
Your content goes here. Edit or remove this text inline or in the module Content settings. You can also style every aspect of this content in the module Design settings and even apply custom CSS to this text in the module Advanced settings.
August 14 - 16, 2026
Day(s)
:
Hour(s)
:
Minute(s)
:
Second(s)
Contact
For more information, please contact the Congress Secretariat, Simply Eventful Management